expansion – Page 3

Roche expands obesity pipeline, paying Zealand Pharma $1.65B upfront to codevelop amylin asset

6 months ago talkbio0Tagged competitive weight loss medication, drug pipeline, expansion, Obesity, Partnership, Roche 's

This deal represents a major expansion of Roche’s obesity drug pipeline and a significant partnership in the competitive weight loss medication market.

Siemens Healthineers Expands U.S. Supply Chain with Strategic ‘Mega Depots’ to Combat Logistics Challenges

7 months ago talkbio0Tagged Equipment and supply inventories, expansion, GXO, Health care facility, Logistics, mega depots, Partnership, Siemens Healthineers

Siemens Healthineers, supply chain resilience, mega depots, logistics expansion, healthcare equipment, parts inventory, GXO partnership

Axplora Invests €50M in GLP-1 Manufacturing Expansion at Mourenx, France

7 months ago talkbio0Tagged alpha 1-antitrypsin, Axplora, biology (field), CDMO, Chromatography, Diabetes, expansion, France, Glucagon-Like Peptide 1, Manufacturing, Mourenx, Obesity, production

Axplora, GLP-1, manufacturing expansion, Mourenx, France, CDMO, API production, chromatography, diabetes, obesity, biologic therapies

Eisai Anticipates Growth Acceleration for Alzheimer’s Drug Leqembi Despite Slow Initial Uptake

7 months ago talkbio0Tagged Adoption, Alzheimer 's disease, Diagnostics, dosing, Eisai, expansion, Growth, Leqembi, Maintenance, Phase, Sales - occupational activity

Leqembi, Alzheimer’s disease, Eisai, expansion phase, sales growth, diagnostics, maintenance dosing, patient adoption

2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes

7 months ago talkbio0Tagged Administration occupational activities, ambulatory care services, Aortic Valve Insufficiency, deal activity, digital health, expansion, Gene Modification, Health care facility, Pharmaceutical Services, regulatory environment, Transplant Registry Unified Management Program

AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration

AstraZeneca Invests $570M in Canadian Expansion, Creating 700 New Jobs

8 months ago talkbio0Tagged AstraZeneca, Canadian, Clinical Trials, Drug Industry, expansion, Investments, R&D

AstraZeneca, Canadian expansion, $570M investment, 700 new jobs, life sciences, R&D, clinical trials, pharmaceutical industry

GSK’s Strategic Approach to Deal-Making and Expansion Beyond Obesity with GLP-1s

8 months ago talkbio0Tagged deal-making, expansion, GLP-1s, Obesity, pharmaceutical innovation, R&D strategy, SmithKline Beecham, strategic

GSK, GLP-1s, Obesity, Deal-making, Strategic expansion, Pharmaceutical innovation, R&D strategy

Samsung Biologics Embarks on New Phase of Growth with Bio Campus II and ADC Services

8 months ago talkbio0Tagged Antibody-Drug Conjugates, Bio Campus II, Biological Factors, Capacity, CDMO, Contract agreement, development aspects, digital transformation, expansion, Manufacturing Organization, Plants, Samsung, Services

Samsung Biologics, Bio Campus II, Plant 5, antibody-drug conjugate (ADC) services, capacity expansion, digital transformation, contract development and manufacturing organization (CDMO)